首页> 外文OA文献 >Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant Chronic–Phase Chronic Myeloid Leukemia

【2h】

Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant Chronic–Phase Chronic Myeloid Leukemia

机译：亚洲耐用慢性慢性慢性骨髓白血病亚洲和白色患者BCR-ABL1激酶结构域突变频率和敏感性的比较

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hawk Kim; SooHyun Kim; Hyeoung-Joon Kim; Yeo-Kyeoung Kim; Jae-Yong Kwak; Ho-Young Yhim; Sung-Hyun Kim; Young Rok Do; Sukjoong Oh; Sung-Eun Lee; Saengsuree Jootar; Jiu Wei Cui; Dong-Wook Kim;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant Chronic–Phase Chronic Myeloid Leukemia [J] . Hawk Kim, SooHyun Kim, Hyeoung-Joon Kim, Clinical lymphoma, myeloma & leukemia . 2018,第10期

机译：亚洲耐药慢性期慢性骨髓白血病亚洲和白色患者BCR-ABL1激酶结构域突变频率和敏感性的比较
2. Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase. [J] . Katerina Machova Polakova, Vojtech Kulvait, Adela Benesova, Journal of Cancer Research and Clinical Oncology . 2015,第5期

机译：下一代深度测序可改善对慢性期白血病患者的酪氨酸激酶抑制剂治疗下出现的BCR-ABL1激酶结构域突变的检测。
3. Presence of a new BCR-ABL kinase domain mutation, C330G in an imatinib naive patient with chronic myeloid leukemia: very low prevalence of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia from eastern India. [J] . Kuila N, Dash N, Sahoo DP, Leukemia and lymphoma . 2009,第4期

机译：在患有伊马替尼的慢性髓样白血病患者中存在新的BCR-ABL激酶结构域突变C330G：来自印度东部的慢性髓样白血病患者中BCR-ABL激酶结构域突变的患病率非常低。
4. Novel Inhibitors of T315I Mutant BCR-ABL1 Tyrosine Kinase for Chronic Myeloid Leukemia Disease Through Fragment-Based Drug Design [C] . Satya Anindita, Atika Marnolia, Hersal Hermana Putra, International symposium on bioinformatics research and applications . 2018

机译：T315I突变BCR-ABL1酪氨酸激酶的新型抑制剂通过基于片段的药物设计治疗慢性粒细胞白血病
5. New strategies for targeted chronic myeloid leukemia therapy: Disrupting BCR-ABL1 dimerization and secondary leukemia-specific pathways [D] . Woessner, David W. 2013

机译：针对性慢性粒细胞白血病治疗的新策略：破坏BCR-ABL1二聚化和继发性白血病特异性途径
6. Choosing the Best Second-Line Tyrosine Kinase Inhibitor in Imatinib-Resistant Chronic Myeloid Leukemia Patients Harboring Bcr-Abl Kinase Domain Mutations: How Reliable Is the IC50? [O] . Simona Soverini, Gianantonio Rosti, Ilaria Iacobucci, 2011

机译：在具有Bcr-Abl激酶结构域突变的伊马替尼耐药的慢性粒细胞白血病患者中选择最佳的二线酪氨酸激酶抑制剂：IC50的可靠性如何？
7. Choosing the Best Second-Line Tyrosine Kinase Inhibitor in Imatinib-Resistant Chronic Myeloid Leukemia Patients Harboring Bcr-Abl Kinase Domain Mutations: How Reliable Is the IC50? [O] . Soverini, Simona, Rosti, Gianantonio, Iacobucci, Ilaria, 2011

机译：在具有Bcr-Abl激酶结构域突变的伊马替尼耐药的慢性粒细胞白血病患者中选择最佳的二线酪氨酸激酶抑制剂：IC50的可靠性如何？

Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant Chronic–Phase Chronic Myeloid Leukemia

著录项

引文网络

相似文献

相关主题

期刊订阅